Literature DB >> 34813048

Using Protection Motivation Theory to Predict Intentions for Breast Cancer Risk Management: Intervention Mechanisms from a Randomized Controlled Trial.

Claire C Conley1, Karen J Wernli2, Sarah Knerr3, Tengfei Li4, Kathleen Leppig5, Kelly Ehrlich2, David Farrell6, Hongyuan Gao2, Erin J A Bowles2, Amanda L Graham1,7, George Luta4, Jinani Jayasekera1, Jeanne S Mandelblatt1, Marc D Schwartz1, Suzanne C O'Neill8.   

Abstract

The purpose of this study is to evaluate the direct and indirect effects of a web-based, Protection Motivation Theory (PMT)-informed breast cancer education and decision support tool on intentions for risk-reducing medication and breast MRI among high-risk women. Women with ≥ 1.67% 5-year breast cancer risk (N = 995) were randomized to (1) control or (2) the PMT-informed intervention. Six weeks post-intervention, 924 (93% retention) self-reported PMT constructs and behavioral intentions. Bootstrapped mediations evaluated the direct effect of the intervention on behavioral intentions and the mediating role of PMT constructs. There was no direct intervention effect on intentions for risk-reducing medication or MRI (p's ≥ 0.12). There were significant indirect effects on risk-reducing medication intentions via perceived risk, self-efficacy, and response efficacy, and on MRI intentions via perceived risk and response efficacy (p's ≤ 0.04). The PMT-informed intervention effected behavioral intentions via perceived breast cancer risk, self-efficacy, and response efficacy. Future research should extend these findings from intentions to behavior. ClinicalTrials.gov Identifier: NCT03029286 (date of registration: January 24, 2017).
© 2021. The Author(s).

Entities:  

Keywords:  Breast cancer; Magnetic resonance imaging (MRI); Prevention; Protection Motivation Theory; Risk management; Risk-reducing medication

Year:  2021        PMID: 34813048      PMCID: PMC9124715          DOI: 10.1007/s13187-021-02114-y

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   1.771


  20 in total

1.  Association of Medication Beliefs, Self-efficacy, and Adherence in a Diverse Cohort of Adults with Rheumatoid Arthritis.

Authors:  Caroline McCulley; Patricia Katz; Laura Trupin; Edward H Yelin; Jennifer L Barton
Journal:  J Rheumatol       Date:  2018-09-15       Impact factor: 4.666

2.  Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention.

Authors:  Andrew N Freedman; Barry I Graubard; Sowmya R Rao; Worta McCaskill-Stevens; Rachel Ballard-Barbash; Mitchell H Gail
Journal:  J Natl Cancer Inst       Date:  2003-04-02       Impact factor: 13.506

3.  Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

Authors:  Heidi D Nelson; Rongwei Fu; Bernadette Zakher; Miranda Pappas; Marian McDonagh
Journal:  JAMA       Date:  2019-09-03       Impact factor: 56.272

4.  A web-based personalized risk communication and decision-making tool for women with dense breasts: Design and methods of a randomized controlled trial within an integrated health care system.

Authors:  Sarah Knerr; Karen J Wernli; Kathleen Leppig; Kelly Ehrlich; Amanda L Graham; David Farrell; Chalanda Evans; George Luta; Marc D Schwartz; Suzanne C O'Neill
Journal:  Contemp Clin Trials       Date:  2017-02-28       Impact factor: 2.226

Review 5.  Psychosocial factors in medication adherence and diabetes self-management: Implications for research and practice.

Authors:  Jeffrey S Gonzalez; Molly L Tanenbaum; Persis V Commissariat
Journal:  Am Psychol       Date:  2016-10

6.  Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer.

Authors:  Jeffrey A Tice; Diana L Miglioretti; Chin-Shang Li; Celine M Vachon; Charlotte C Gard; Karla Kerlikowske
Journal:  J Clin Oncol       Date:  2015-08-17       Impact factor: 44.544

7.  A System-Level Approach to Improve the Uptake of Antiestrogen Preventive Therapy among Women with Atypical Hyperplasia and Lobular Cancer In Situ.

Authors:  Abenaa M Brewster; Priya Thomas; Powel Brown; Robin Coyne; Yuanqing Yan; Cristina Checka; Lavinia Middleton; Kim-Anh Do; Therese Bevers
Journal:  Cancer Prev Res (Phila)       Date:  2018-04-04

8.  Patterns of breast magnetic resonance imaging use in community practice.

Authors:  Karen J Wernli; Wendy B DeMartini; Laura Ichikawa; Constance D Lehman; Tracy Onega; Karla Kerlikowske; Louise M Henderson; Berta M Geller; Mike Hofmann; Bonnie C Yankaskas
Journal:  JAMA Intern Med       Date:  2014-01       Impact factor: 21.873

Review 9.  Is patient empowerment the key to promote adherence? A systematic review of the relationship between self-efficacy, health locus of control and medication adherence.

Authors:  Lilla Náfrádi; Kent Nakamoto; Peter J Schulz
Journal:  PLoS One       Date:  2017-10-17       Impact factor: 3.240

10.  Effect of Personalized Breast Cancer Risk Tool on Chemoprevention and Breast Imaging: ENGAGED-2 Trial.

Authors:  Karen J Wernli; Sarah Knerr; Tengfei Li; Kathleen Leppig; Kelly Ehrlich; David Farrell; Hongyuan Gao; Erin J A Bowles; Amanda L Graham; George Luta; Jinani Jayasekera; Jeanne S Mandelblatt; Marc D Schwartz; Suzanne C O'Neill
Journal:  JNCI Cancer Spectr       Date:  2021-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.